If the stock can firm up here, we see overhead resistance around the $48-$50 price levels. We would stay on the sidelines for now. Abbott Laboratories (ABT) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out …
Abbott Laboratories ABT is scheduled to report third-quarter 2016 results before the opening bell on Oct 19. Last quarter, Abbott Labs delivered a positive earnings surprise of 3.77%. Let’s see how things are shaping up for this quarter. …
Chicago-headquartered Abbott announced Thursday it is acquiring Minnesota-based St. Jude Medical in a cash-and-stock deal worth about $25 billion. The acquisition, subject to regulatory approvals, will strengthen Abbott's position in the …
A federal judge recently sentenced the last two of 34 Aryan Brotherhood of Texas (ABT) gang members to prison for their roles in a methamphetamine drug distribution network. The FBI claimed it marked the end of the gang’s foothold in …
The most recent increase to the dividend was in January, when the quarterly payout on ABT stock was hiked by 9% to 24 cents. At current prices, ABT yields 2% — meaning Abbott isn’t necessarily a significant source of income, but it still …
We decided to perform a fair value analysis for Abbott using out discounted earnings model. As of January 31, 2013, ABT stock was trading at around $36.39, with a 52-week range of $33.33 - $38.52. It has a market cap of about $53.6 billion. …
Today’s short video takes a closer look at Abbott Labs (ABT) stock ahead of their earnings report. The company has seen extremely choppy trading as of late, and it will be up to this coming release to right the ship. Fortunately for ABT
The scenario assumes ABT stock, which pays a quarterly dividend of 48 cents a share (yielding 3.5% annually), was purchased at $52.25 in June of 2011 when the market bounced off spring lows, and out-of-the-money calls were sold …
Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number ABT is trading at a discount to only 1) above. When also considering the NPV MMA Differential, the stock is trading at a slight premium to its calculated fair …